| Dr Latesha I Dawson Thomas, MD | |
|
99 Ash St, Uconn Medical Group-pediatrics, East Hartford, CT 06108-3226 | |
| (860) 282-3859 | |
| (860) 282-8574 |
| Full Name | Dr Latesha I Dawson Thomas |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 99 Ash St, East Hartford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497925044 | NPI | - | NPPES |
| 1497925044 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 046993 (Connecticut) | Primary |
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) approved the use of Advair 100/50 in children four years to eleven years of age with asthma who are symptomatic on inhaled corticosteroid therapy alone.
In light of Prostate Cancer Awareness month, integrative medicine pioneer and cancer expert Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer. As a well known specialist in the field of integrative prostate cancer therapy, Dr. Eliaz strategically combines ancient and modern healing modalities into a holistic practice of medicine by successfully incorporating the most effective and well researched therapies available in conventional and complementary medicine.
Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition.
American Oriental Bioengineering, Inc. today announced that the Company has launched a new product for the rhinitis and allergy market, called Jingwei Capsules ("Jingwei"). Jingwei will be manufactured by the Company's Boke subsidiary, and will be marketed throughout China utilizing AOBO's distribution network, including the Company's national hospital and pharmacy distribution network.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Latesha I Dawson Thomas, MD 264 Farmington Avenue, Provider Enrollment, Farmington, CT 06030-2212 Ph: (860) 679-7503 | Dr Latesha I Dawson Thomas, MD 99 Ash St, Uconn Medical Group-pediatrics, East Hartford, CT 06108-3226 Ph: (860) 282-3859 |
News Archive
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) approved the use of Advair 100/50 in children four years to eleven years of age with asthma who are symptomatic on inhaled corticosteroid therapy alone.
In light of Prostate Cancer Awareness month, integrative medicine pioneer and cancer expert Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer. As a well known specialist in the field of integrative prostate cancer therapy, Dr. Eliaz strategically combines ancient and modern healing modalities into a holistic practice of medicine by successfully incorporating the most effective and well researched therapies available in conventional and complementary medicine.
Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition.
American Oriental Bioengineering, Inc. today announced that the Company has launched a new product for the rhinitis and allergy market, called Jingwei Capsules ("Jingwei"). Jingwei will be manufactured by the Company's Boke subsidiary, and will be marketed throughout China utilizing AOBO's distribution network, including the Company's national hospital and pharmacy distribution network.
› Verified 7 days ago
Dr. Sheikh Irfan Ahmed, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 580 Burnside Ave, Suite 4, East Hartford, CT 06108 Phone: 860-528-5068 Fax: 860-528-2341 | |
Eugene Fantl, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 99 Ash St, East Hartford, CT 06108 Phone: 860-282-3859 Fax: 860-282-8574 | |
Dr. Jayashree Venkatesh, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 893 Main St, Suite 303, East Hartford, CT 06108 Phone: 860-289-3047 Fax: 860-528-4735 | |
Larry Scherzer, Pediatrics Medicare: Medicare Enrolled Practice Location: 99 Ash St, East Hartford, CT 06108 Phone: 860-282-3859 |